Drug class
Aminoglycoside antibacterial agent
Mechanism of action
Binds to the bacterial 30S ribosomal subunit and inhibits protein synthesis, producing concentration-dependent bactericidal activity against susceptible Enterobacteriaceae.
General use cases
- Treatment of adults with complicated urinary tract infection, including pyelonephritis, caused by designated susceptible Enterobacteriaceae when limited or no alternative treatment options are available, under the product label.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
